These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17878766)

  • 1. Probucol does not inhibit myeloperoxidase-dependent low-density lipoprotein oxidation as a potent protective effect in atherosclerosis.
    Van Antwerpen P; Néve J; Moreau P; Boudjeltia KZ; Vanhaeverbeek M; Prévost M; Babar S; Legssyer I; Moguilevsky N; Ducobu J
    J Cardiovasc Pharmacol; 2007 Sep; 50(3):350-1. PubMed ID: 17878766
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of lipid peroxidation products and antioxidants on the formation of probucol radical in low density lipoproteins.
    Shumaev KB; Ruuge EK; Dmitrovsky AA; Bykhovsky VYa ; Kukharchuk VV
    Biochemistry (Mosc); 1997 Jun; 62(6):657-60. PubMed ID: 9284547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyronines and probucol inhibition of human capillary endothelial cell-induced low density lipoprotein oxidation.
    Hanna AN; Titterington LC; Lantry LE; Stephens RE; Newman HA
    Biochem Pharmacol; 1995 Nov; 50(10):1627-33. PubMed ID: 7503765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of probucol on low density lipoprotein oxidation and femoral atherosclerosis.
    Regnström J; Walldius G; Nilsson S; Elinder LS; Johansson J; Mölgaard J; Holme I; Olsson AG; Nilsson J
    Atherosclerosis; 1996 Sep; 125(2):217-29. PubMed ID: 8842353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Captopril inhibits the oxidative modification of apolipoprotein B-100 caused by myeloperoxydase in a comparative in vitro assay of angiotensin converting enzyme inhibitors.
    Van Antwerpen P; Legssyer I; Zouaoui Boudjeltia K; Babar S; Moreau P; Moguilevsky N; Vanhaeverbeek M; Ducobu J; Nève J
    Eur J Pharmacol; 2006 May; 537(1-3):31-6. PubMed ID: 16631159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antioxidant probucol is an efficient trap for lipid radicals in LDL in vitro and in vivo].
    Tikhaze AK; Lankin VZ; Konovalova GG; Shumaev KB; Kaminnyĭ AI; Kozachenko AI; Gurevich SM; Nagler LG; Zaĭtseva TM; Kukharchuk VV
    Biull Eksp Biol Med; 1999 Aug; 127(8):186-9. PubMed ID: 11188741
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of lipid hydroperoxidation of low density lipoprotein by the Ca(2+)-channel and alpha 1-adrenoceptor antagonist monatepil maleate.
    Hayashi K; Kuga Y; Nomura S; Okura Y; Tanaka K; Yasunobu Y; Nomura K; Shingu T; Kuwashima J; Kajiyama G
    Arzneimittelforschung; 1996 Apr; 46(4):378-81. PubMed ID: 8740082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic diarylheptanoids inhibit cell mediated low-density lipoprotein oxidation.
    Kang HM; Ryong Kim J; Jeomg TS; Choi SG; Ryu YH; Taeg Oh G; Baek NI; Kwon BM
    Nat Prod Res; 2006 Jan; 20(1):37-41. PubMed ID: 16286306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and evaluation of pharmacological properties of cinnamic derivatives as antiatherogenic agents.
    Lapeyre C; Delomenède M; Bedos-Belval F; Duran H; Nègre-Salvayre A; Baltas M
    J Med Chem; 2005 Dec; 48(26):8115-24. PubMed ID: 16366593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin E or probucol as donors for oxidation of human low-density lipoprotein by peroxidases/H2O2.
    Braun S; von Bruchhausen F
    Pharmacology; 1994 Nov; 49(5):325-35. PubMed ID: 7862745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of probucol on the course of free radical oxidation in experimental dust bronchitis].
    Kulkybaev GA; Dosmagambetova RS; Al'kina SV
    Med Tr Prom Ekol; 1999; (11):43-6. PubMed ID: 10605291
    [No Abstract]   [Full Text] [Related]  

  • 12. Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein.
    Byun J; Mueller DM; Fabjan JS; Heinecke JW
    FEBS Lett; 1999 Jul; 455(3):243-6. PubMed ID: 10437781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine-enhanced oxidation of low-density lipoprotein and its components by myeloperoxidase/H₂O₂/Cl- system.
    Oliveira OM; Brunetti IL; Khalil NM
    An Acad Bras Cienc; 2015 Mar; 87(1):183-92. PubMed ID: 25806984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between LDL oxidation and macrophage myeloperoxidase activity.
    Wu J; Liu Y; Li X; Chen L; Xia L; Hong J
    Chin Med J (Engl); 2003 May; 116(5):791-3. PubMed ID: 12875704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved method for the sensitive monitoring of low density lipoprotein modification by myeloperoxidase.
    Jerlich A; Hammel M; Horakova L; Schaur RJ
    Redox Rep; 2001; 6(4):257-64. PubMed ID: 11642717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis of human low-density lipoprotein reveals the presence of prenylcysteine lyase, a hydrogen peroxide-generating enzyme.
    Banfi C; Brioschi M; Barcella S; Wait R; Begum S; Galli S; Rizzi A; Tremoli E
    Proteomics; 2009 Mar; 9(5):1344-52. PubMed ID: 19253276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antioxidant probucol on cell-mediated LDL oxidation in vitro and in vivo.
    Bilenko MV; Khil'chenko AV; Konovalova GG; Lankin VZ
    Bull Exp Biol Med; 2003 Aug; 136(2):126-8. PubMed ID: 14631489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on the antioxidant activities of nine common food legumes against copper-induced human low-density lipoprotein oxidation in vitro.
    Xu BJ; Yuan SH; Chang SK
    J Food Sci; 2007 Sep; 72(7):S522-7. PubMed ID: 17995667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholesterol turnover in triglyceride transport and effect of probucol].
    Titov VN
    Vopr Med Khim; 1995; 41(5):2-8. PubMed ID: 8553619
    [No Abstract]   [Full Text] [Related]  

  • 20. Myeloperoxidase/nitrite-mediated lipid peroxidation of low-density lipoprotein as modulated by flavonoids.
    Kostyuk VA; Kraemer T; Sies H; Schewe T
    FEBS Lett; 2003 Feb; 537(1-3):146-50. PubMed ID: 12606047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.